Apoptosis

, Volume 17, Issue 12, pp 1316–1326 | Cite as

Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins

Original Paper

Abstract

We investigated whether snake venom toxin (SVT) from Vipera lebetina turanica enhances the apoptosis ability of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in cancer cells. TRAIL inhibited HCT116 cell growth in a dose-dependent manner; however, this reduction did not occur in TRAIL resistant HT-29, A549 and HepG2 cells with an even higher dose of TRAIL. SVT, but not TRAIL enhanced expression of cell death receptor (DR) in TRAIL resistant cancer cells in a dose-dependent manner. A combination of SVT with TRAIL significantly inhibited cell growth of TRAIL resistant HT-29, A549 and HepG2 cells. Consistent with cell growth inhibition, the expression of TRAIL receptors; DR4 and DR5 was significantly increased as well as apoptosis related proteins such as cleaved caspase-3, -8, -9 and Bax. However, the expression of survival proteins (e.g., cFLIP, survivin, XIAP and Bcl2) was suppressed by the combination treatment of SVT and TRAIL. Depletion of DR4 or DR5 by small interfering RNA significantly reversed the cell growth inhibitory and apoptosis blocking effects of SVT in HCT116 and HT-29 cells. Pretreatment with the c-Jun N-terminal kinase (JNK) inhibitor SP600125 and the reactive oxygen species (ROS) scavenger N-acetylcysteine reduced the SVT and TRAIL-induced upregulation of DR4 and DR5 expression, expression of the apoptosis related protein such as caspase-3 and-9, as well as cell growth inhibitory effects. The collective results suggest that SVT facilitates TRAIL-induced apoptosis in cancer cells through up-regulation of the TRAIL receptors; DR4 and DR5 via ROS/JNK pathway signals.

Keywords

SVT TRAIL DR4 DR5 ROS JNK 

Supplementary material

10495_2012_759_MOESM1_ESM.docx (91 kb)
Supplementary material 1 (DOCX 91 kb)

References

  1. 1.
    Koschny R, Walczak H, Ganten TM (2007) The promise of TRAIL: potential and risks of a novel anticancer therapy. J Mol Med 85:923–935PubMedCrossRefGoogle Scholar
  2. 2.
    Johnstone RW, Frew AJ, Smyth MJ (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8:782–798PubMedCrossRefGoogle Scholar
  3. 3.
    Bin L, Thorburn J, Thomas LR, Clark PE, Humphreys R, Thorburn A (2007) Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding. J Biol Chem 282:28189–28194PubMedCrossRefGoogle Scholar
  4. 4.
    Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY et al (2001) Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin’s lymphoma. Oncogene 20:399–403PubMedCrossRefGoogle Scholar
  5. 5.
    Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S (1999) Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59:734–741PubMedGoogle Scholar
  6. 6.
    Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT (2001) Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res 61:1645–1651PubMedGoogle Scholar
  7. 7.
    Prasad S, Yadav VR, Kannappan R, Aggarwal BB (2011) Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK. J Biol Chem 286:5546–5557PubMedCrossRefGoogle Scholar
  8. 8.
    Prasad S, Yadav VR, Ravindran J, Aggarwal BB (2011) ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins. Cancer Res 71:538–549PubMedCrossRefGoogle Scholar
  9. 9.
    Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB (2010) Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. J Biol Chem 285:35418–35427PubMedCrossRefGoogle Scholar
  10. 10.
    Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, Kwon TK (2005) Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26:1905–1913PubMedCrossRefGoogle Scholar
  11. 11.
    Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M et al (2008) Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res 68:8918–8927PubMedCrossRefGoogle Scholar
  12. 12.
    Su RY, Chi KH, Huang DY, Tai MH, Lin WW (2008) 15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription. Mol Cancer Ther 7:3429–3440PubMedCrossRefGoogle Scholar
  13. 13.
    Poh TW, Huang S, Hirpara JL, Pervaiz S (2007) LY303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization. Cell Death Differ 14:1813–1825PubMedCrossRefGoogle Scholar
  14. 14.
    Ohtsuka T, Zhou T (2002) Bisindolylmaleimide VIII enhances DR5-mediated apoptosis through the MKK4/JNK/p38 kinase and the mitochondrial pathways. J Biol Chem 277:29294–29303PubMedCrossRefGoogle Scholar
  15. 15.
    Wang C, Chen T, Zhang N, Yang M, Li B, Lü X et al (2009) Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha kinase-NFkappaB. J Biol Chem 284:3804–3813PubMedCrossRefGoogle Scholar
  16. 16.
    Horita H, Thorburn J, Frankel AE, Thorburn A (2009) EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins. J Neurooncol 95:175–184PubMedCrossRefGoogle Scholar
  17. 17.
    Son DJ, Park MH, Chae SJ, Moon SO, Lee JW, Song HS et al (2007) Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor kappaB. Mol Cancer Ther 6:675–683PubMedCrossRefGoogle Scholar
  18. 18.
    Lewis RJ, Garcia ML (2003) Therapeutic potential of venom peptides. Nat Rev Drug Discov 2:790–802PubMedCrossRefGoogle Scholar
  19. 19.
    Nasiripourdori A, Taly V, Grutter T, Taly A (2011) From toxins targeting ligand gated ion channels to therapeutic molecules. Toxins (Basel) 3:260–293Google Scholar
  20. 20.
    Birrell GW, Earl ST, Wallis TP, Masci PP, de Jersey J, Gorman JJ et al (2007) The diversity of bioactive proteins in Australian Snake Venoms. Mol Cell Proteomics 6(2007):973–986PubMedGoogle Scholar
  21. 21.
    Paleari L, Cesario A, Fini M, Russo P (2009) alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? Drug Discov Today 14:822–836PubMedCrossRefGoogle Scholar
  22. 22.
    Park MH, Son DJ, Kwak DH, Song HS, Oh KW, Yoo HS et al (2009) Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells. Arch Pharm Res 32:1545–1554PubMedCrossRefGoogle Scholar
  23. 23.
    Park MH, Jo MR, Won D, Song HS, Han SB, Song MJ, Hong JT (2012) Snake venom toxin from Vipera lebetina turanica induces apoptosis in colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression. BMC Cancer 12:228PubMedCrossRefGoogle Scholar
  24. 24.
    Rauert H, Stühmer T, Bargou R, Wajant H, Siegmund D (2011) TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death Dis 2:e194PubMedCrossRefGoogle Scholar
  25. 25.
    Yadav VR, Prasad S, Aggarwal BB (2012) Cardamonin sensitizes tumor cells to TRAIL through ROS- and CHOP-mediated upregulation of death receptors and downregulation of survival proteins. Br J Pharmacol 165:741–753PubMedCrossRefGoogle Scholar
  26. 26.
    Ashkenazi A, Herbst RS (2008) To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 118:1979–1990PubMedCrossRefGoogle Scholar
  27. 27.
    Eberle J, Fecker LF, Forschner T, Ulrich C, Röwert-Huber J, Stockfleth E (2007) Apoptosis pathways as promising targets for skin cancer therapy. Br J Dermatol 156:18–24PubMedCrossRefGoogle Scholar
  28. 28.
    Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F, de Jong S (2010) Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys Acta 1805:123–140PubMedGoogle Scholar
  29. 29.
    Jung YH, Heo J, Lee YL, Kwon TK, Kim YH (2010) Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sci 86:351–357PubMedCrossRefGoogle Scholar
  30. 30.
    Kim MO, Moon DO, Kang CH, Kwon TK, Choi YH, Kim GY (2010) beta-Ionone enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells through Sp1-dependent upregulation of DR5 and downregulation of NF-kappa B activity. Mol Cancer Ther 9:833–843PubMedCrossRefGoogle Scholar
  31. 31.
    Wang S, El-Deiry WS (2003) TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22:8628–8633PubMedCrossRefGoogle Scholar
  32. 32.
    Jäättelä M (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res 248:30–43PubMedCrossRefGoogle Scholar
  33. 33.
    Prasad S, Ravindran J, Sung B, Pandey MK, Aggarwal BB (2010) Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins. Mol Cancer Ther 9:856–868PubMedCrossRefGoogle Scholar
  34. 34.
    Kim YH, Lee DH, Jeong JH, Guo ZS, Lee YJ (2008) Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem Pharmacol 75:1946–1958PubMedCrossRefGoogle Scholar
  35. 35.
    Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A (2007) Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 6:2591–2599PubMedCrossRefGoogle Scholar
  36. 36.
    Sung B, Park B, Yadav VR, Aggarwal BB (2010) Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J Biol Chem 285:11498–11507PubMedCrossRefGoogle Scholar
  37. 37.
    Park SK, Sanders BG, Kline K (2010) Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res Treat 124:361–375PubMedCrossRefGoogle Scholar
  38. 38.
    Fu L, Lin YD, Elrod HA, Yue P, Oh Y, Li B et al (2010) c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL. Mol Cancer 9:315PubMedCrossRefGoogle Scholar
  39. 39.
    Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, Lee SJ et al (2006) Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res 66:1740–1750PubMedCrossRefGoogle Scholar
  40. 40.
    Yodkeeree S, Sung B, Limtrakul P, Aggarwal BB (2009) Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen species. Cancer Res 69:6581–6589PubMedCrossRefGoogle Scholar
  41. 41.
    Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB et al (2012) Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmacol 258:72–81PubMedCrossRefGoogle Scholar
  42. 42.
    Ip SW, Liao SS, Lin SY, Lin JP, Yang JS, Lin ML et al (2008) The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells. In Vivo 22:237–245PubMedGoogle Scholar
  43. 43.
    Tu WC, Wu CC, Hsieh HL, Chen CY, Hsu SL (2008) Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells. Toxicon 52:318–329PubMedCrossRefGoogle Scholar
  44. 44.
    Kim CN, Bhalla K, Kreitman RJ, Willingham MC, Hall P, Tagge EP et al (1999) Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor and Ara-C exert synergistic toxicity against human AML HL-60 cells. Leuk Res 23:527–538PubMedCrossRefGoogle Scholar
  45. 45.
    Serrano SM, Maroun RC (2005) Snake venom serine proteinases: sequence homology vs. substrate specificity, a paradox to be solved. Toxicon 45:1115–1132PubMedCrossRefGoogle Scholar
  46. 46.
    Gorbacheva EV, Starkov VG, Tsetlin VI, Utkin YN, Vulfius (2008) Viperidae snake venoms block nicotinic acetylcholine receptors and voltage-gated Ca2+ channels in identified neurons of fresh-water snail Lymnaea stagnalis. Biochemistry (Moscow) Suppl A2:14–18Google Scholar
  47. 47.
    Ye YN, Liu ES, Shin VY, Wu WK, Cho CH (2004) The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther 311:123–130PubMedCrossRefGoogle Scholar
  48. 48.
    Amm HM, Oliver PG, Lee CH, Li Y, Buchsbaum DJ (2011) Combined modality therapy with TRAIL or agonistic death receptor antibodies. Cancer Biol Ther 11:431–449PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.College of Pharmacy and Medical Research CenterChungbuk National UniversityCheongjuSouth Korea
  2. 2.College of Oriental MedicineKyungwon UniversitySeongnamSouth Korea
  3. 3.Obstetrics and Gynecology, Seoul St.Mary’s HospitalThe Catholic University Korea, KoreaSeoulSouth Korea

Personalised recommendations